Article Versions Notes

Nock BA, Kanellopoulos P, Moon ES, Rouchota M, Loudos G, Ballal S, Yadav MP, Bal C, Mishra P, Sheokand P, et al. [¹¹¹In]In/[¹⁷⁷Lu]Lu-AAZTA⁵-LM4 SST₂R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results. Pharmaceutics. 2023; 15(3):776. https://doi.org/10.3390/pharmaceutics15030776

Nock, Berthold A., Panagiotis Kanellopoulos, Euy Sung Moon, Maritina Rouchota, George Loudos, Sanjana Ballal, Madhav P. Yadav, Chandrasekhar Bal, Prashant Mishra, Parvind Sheokand, and et al. 2023. "[¹¹¹In]In/[¹⁷⁷Lu]Lu-AAZTA⁵-LM4 SST₂R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results" Pharmaceutics 15, no. 3: 776. https://doi.org/10.3390/pharmaceutics15030776

Nock, B. A., Kanellopoulos, P., Moon, E. S., Rouchota, M., Loudos, G., Ballal, S., Yadav, M. P., Bal, C., Mishra, P., Sheokand, P., Roesch, F., & Maina, T. (2023). [¹¹¹In]In/[¹⁷⁷Lu]Lu-AAZTA⁵-LM4 SST₂R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results. Pharmaceutics, 15(3), 776. https://doi.org/10.3390/pharmaceutics15030776